SecBot SecBot
144 ·Filed Nov 13, 2026

RCKT

ROCKET PHARMACEUTICALS, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed3d 10h ago SEC0001959173-26-008010
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The filing is a routine intent-to-sell notice for a small number of shares, likely for tax withholding on equity vesting. No material impact on stock price expected. Monitor future Form 4 filings to confirm actual sale and any change in insider selling patterns.

DirectionNeutral
Confidencehigh
Horizonimmediate

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Gaurav Shah, an officer and director of Rocket Pharmaceuticals, filed a Form 144 notice of intent to sell 3,020 shares of common stock, with an approximate market value of $6,796 as of the filing date. The shares were acquired through restricted stock vesting on November 11, 2026, and the sale appears to be a routine, small disposition likely to cover tax obligations from equity vesting. Given the trivial size relative to the company's $272M market cap and the insider's prior pattern of small sales, this filing is neutral and not material.

Key Facts

  • Insider Gaurav Shah (Officer and Director) filed Form 144 to sell 3,020 shares of common stock.
  • Estimated value of the proposed sale is approximately $6,796 based on the filing date.
  • Shares were acquired via restricted stock vesting on November 11, 2026.
  • The filing notes a prior sale on August 18, 2026, of 2,293 shares for $7,754, described as covering a tax obligation from vested equity award distribution.
  • Company market cap is $272M; the proposed sale represents about 0.0025% of market cap.
  • Recent insider activity (30 days) shows 2 sells totaling $139K, consistent with small routine dispositions.

Financial Impact

Proposed sale of 3,020 shares valued at ~$6,796, negligible relative to $272M market cap.

dilution

Risk Factors

  • Form 144 is only an intent to sell; the sale may not occur.
  • If the insider increases selling volume significantly in future filings, it could signal reduced confidence.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
60% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001959173-26-008010
Document: 0001959173-26-008010-index.html0001959173-26-008010
Document: 0001959173-26-008010.txt0001959173-26-008010

Track record

21 reports on RCKT

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +42.18% at T+20 after the Jun 12, 2026 report. 6 of 6 went positive at some point.

Filters
  1. Nov 13, 20263d ago 144 Neutral 2/10 Viewing Entry $2.45 Now $2.16 −11.84% settles Dec 15
  2. Nov 13, 20263d ago 144 Neutral 2/10 Entry $2.30 Now $2.16 −6.09% settles Dec 14
  3. Nov 12, 20264d ago Insider Cluster Neutral 3/10 Entry $2.30 Now $2.16 −6.09% settles Dec 14
  4. Nov 12, 20264d ago 8-K Neutral 5/10 Entry $2.30 Now $2.16 −6.09% settles Dec 14
  5. Nov 9, 20267d ago 144 Neutral 2/10 Entry $2.53 Now $2.16 −14.62% settles Dec 8
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $2.53 Now $2.16 −14.62% settles Dec 8
  7. Nov 5, 202611d ago 144 Neutral 2/10 Entry $2.44 Now $2.16 −11.29% settles Dec 4
  8. Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $2.44 Now $2.16 −11.48% settles Nov 30
  9. Oct 6, 20265w ago 8-K Bullish 7/10 Entry $2.54 to $2.57 Now $2.16 −14.79% ▲ +1.38% +2.62% vs SPY
  10. Sep 15, 20268w ago 8-K Bullish 7/10 Entry $3.41 to $2.30 Now $2.16 −36.66% ▼ −32.55% −35.27% vs SPY
Showing 10 of 21

US Market Status

Market Closed · Opens in 6h 41m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 13, 2026